Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance ...Middle East

INCHEON, South Korea, Sept. 17, 2023 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today a new agreement with Bristol Myers Squibb (NYSE: BMY) for large-scale manufacturing of a Bristol Myers Squibb commercial antibody cancer drug substance. Bristol Myers Squibb and Samsung...

Hence then, the article about samsung biologics announces expanded strategic agreement with bristol myers squibb to manufacture an antibody cancer drug substance was published today ( Monday 18/09/2023 - 03:05 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance )

Also on site :

• Who Is ShinyHunters? Hacker Group Claiming Canvas, Vimeo, Pornhub Attacks
• Llegó a EE.UU. a los 4 años y soñaba con entrar al Ejército, pero fue deportado a un país que no recuerda
• Anthropic’s Mythos set off a cybersecurity ‘hysteria.’ Experts say the threat was already here